Telomir Pharmaceuticals, Inc.
Pre-clinical pharma company developing a small molecule for aging and chronic disease.
TELO | US
Overview
Corporate Details
- ISIN(s):
- US87975F1049
- LEI:
- Country:
- United States of America
- Address:
- 100 SE 2ND ST, 33131 MIAMI
- Website:
- https://telomirpharma.com/
Description
Telomir Pharmaceuticals, Inc. is a pre-clinical stage pharmaceutical company focused on the development of Telomir-1, its lead product candidate. Telomir-1 is an investigational oral small molecule designed to address the cellular drivers of aging and chronic disease. Its proposed mechanism of action involves regulating intracellular metals, such as iron and copper, to interrupt enzyme function. The therapy aims to extend and protect telomeres, reset abnormal DNA methylation patterns, reduce oxidative stress, and restore mitochondrial function. By targeting these fundamental processes, the company seeks to develop treatments for age-related conditions and specific disorders like Wilson's Disease.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all Telomir Pharmaceuticals, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Telomir Pharmaceuticals, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Telomir Pharmaceuticals, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
